Evidence map›Paper›PMID 28025328›Full record

ArticleHuman molecular genetics2017

Mutations in BOREALIN cause thyroid dysgenesis.

Aurore Carré, Athanasia Stoupa, Dulanjalee Kariyawasam, Manelle Gueriouz, Cyrille Ramond, Taylor Monus, Juliane Léger, Sébastien Gaujoux, Frédéric Sebag, Nicolas Glaser and 10 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01916018 (Phenotype and Genotype Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. The Use of Genetic Analysis in the Early Care of Children With Thyroid Dysgenesis), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01916018 nacompletednot on this map

Phenotype and Genotype Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. The Use of Genetic Analysis in the Early Care of Children With Thyroid Dysgenesis

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2013 to 2017Enrolled558ConditionsCongenital HypothyroidismArmsClinical and radiologic exams and blood samples
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Approach to the patient: genetics and management of congenital hypothyroidism.The Journal of clinical endocrinology and metabolism · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Novel Missense Variants inInternational journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision).Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2023
    Article
  11. Article
  12. Review
  13. Whole-Exome Sequencing in Congenital Hypothyroidism Due to Thyroid Dysgenesis.Thyroid : official journal of the American Thyroid Association · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Genetics of Gland-Frontiers in endocrinology · 2020
    Article
  20. [TUBB1 mutation in children with congenital hypothyroidism and thyroid dysgenesis in Shandong, China].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 2 countries.

Aurore CarréINSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Athanasia StoupaIMAGINE Institute affiliate, Paris, France.
Dulanjalee KariyawasamINSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Manelle GueriouzIMAGINE Institute affiliate, Paris, France.
Cyrille RamondINSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Taylor MonusDepartment of Biological Sciences, University of Toledo, Toledo, Ohio, USA.
Juliane LégerPediatric Endocrinology Unit, Hôpital Universitaire Robert Debré, AP-HP, Paris, France.
Sébastien GaujouxDepartment of Digestive and Endocrine Surgery, Cochin Hospital, AP-HP, Université Paris Descartes, Paris, France.
Frédéric SebagDepartment of General, Endocrine and Metabolic Surgery, Hopital de la Conception, Marseille, France.
Nicolas GlaserINSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Delphine ZenatyPediatric Endocrinology Unit, Hôpital Universitaire Robert Debré, AP-HP, Paris, France.
Patrick NitschkeBioinformatics Platform, Paris Descartes University, IMAGINE Institute, Paris, France.
Christine Bole-FeysotGenomic Platform, INSERM UMR 1163, Paris Descartes Sorbonne Paris Cite University, Imagine Institute, Paris, France.
Laurence HubertINSERM U1163, IMAGINE Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Stanislas LyonnetINSERM U1163, IMAGINE Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Raphaël ScharfmannINSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Arnold MunnichINSERM U1163, IMAGINE Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Claude BesmondINSERM U1163, IMAGINE Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
William TaylorDepartment of Biological Sciences, University of Toledo, Toledo, Ohio, USA.
Michel PolakINSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Sorbonne Paris Cité · FRDélégation Paris 5 · FRHôpital Necker-Enfants Malades · FRInstitut des Maladies Génétiques Imagine · FRUniversity of Toledo · USAssistance Publique – Hôpitaux de Paris · FRHôpital de la Conception · FRHôpital Robert-Debré · FRInserm · FRUniversité Paris Cité · FR

Funding

Regulation of Sororin by Cdk1-mediated Phosphorylation.R15GM100440 · NIGMS · UNIVERSITY OF TOLEDO · PI TAYLOR, WILLIAM R. · 2012 to 2012
$291k
NIGMS NIH HHS R15 GM100440
6 · The paper itself

Abstract

Congenital hypothyroidism is the most common neonatal endocrine disorder and is primarily caused by developmental abnormalities otherwise known as thyroid dysgenesis (TD). We performed whole exome sequencing (WES) in a consanguineous family with TD and subsequently sequenced a cohort of 134 probands with TD to identify genetic factors predisposing to the disease. We identified the novel missense mutations p.S148F, p.R114Q and p.L177W in the BOREALIN gene in TD-affected families. Borealin is a major component of the Chromosomal Passenger Complex (CPC) with well-known functions in mitosis. Further analysis of the missense mutations showed no apparent effects on mitosis. In contrast, expression of the mutants in human thyrocytes resulted in defects in adhesion and migration with corresponding changes in gene expression suggesting others functions for this mitotic protein. These results were well correlated with the same gene expression pattern analysed in the thyroid tissue of the patient with BOREALIN-p.R114W. These studies open new avenues in the genetics of TD in humans.

Indexed as

Genetic Predisposition to DiseaseCell Cycle ProteinsCell MovementExomeFemaleGene Expression RegulationHigh-Throughput Nucleotide SequencingHumansMitosisMutation, MissensePedigreeThyroid DysgenesisCDCA8 protein, humanCell Cycle Proteins

Identifiers

PMID28025328
PMCPMC6311960
OpenAlexW2566882639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.